🔎 Trials Near Me

Hjem › Ulcerøs colitis › Massachusetts

Ulcerøs colitis kliniske forsøg i Massachusetts

16 studier for Ulcerøs colitis søger deltagere på steder i Massachusetts.

Byer i Massachusetts

Officiel studietekst (engelsk)

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

  • Lucida Clinical Trials /ID# 282000, New Bedford
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT07697456

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

  • Gastro Health Research - Framingham, Framingham
  • Lucida Clinical Trials LLC, New Bedford
RekruttererFase 4
Alder 18 til 80 · Alle køn · Opdateret 30. sep. 2026 · NCT06581328

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

  • Site 003, Boston
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 29. sep. 2026 · NCT07012395

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

  • Boston Children's Hospital, Boston
  • University of Massachusetts Chan Medical School, Worcester
RekruttererFase 2/3
Alder 2 til 17 · Alle køn · Opdateret 24. sep. 2026 · NCT05076175

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  • Lucida Clinical Trials, New Bedford
RekruttererFase 3
Alder 18 til 70 · Alle køn · Opdateret 24. sep. 2026 · NCT06937086

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • Massachusetts General Hospital Cancer Center, Boston
  • Dana-Farber Cancer Institute, Boston
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT03816345

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

  • Brigham and Women's Hospital, Boston
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 22. sep. 2026 · NCT07186101

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

  • Boston Children's Hospital, Boston
  • Massachusetts General Hospital, Waltham
RekruttererFase 3
Alder 2 til 19 · Alle køn · Opdateret 22. sep. 2026 · NCT04844606

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

  • Tufts Medical Center - Site Number: 8400126, Boston
  • UMass Memorial Medical Center - Site Number: 8400121, Worcester
RekruttererFase 3
Alder 16 til 80 · Alle køn · Opdateret 20. aug. 2026 · NCT07184996

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

  • Brigham and Women's Hospital, Boston
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 5. aug. 2026 · NCT07237516

Treatment of UC With Novel Therapeutics

  • Brigham and Women's Hospital, Chestnut Hill
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 21. jul. 2026 · NCT06420375

A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

  • Boston Children's Hospital, Boston
RekruttererFase 2
Alder 12 til 17 · Alle køn · Opdateret 8. jul. 2026 · NCT05287126

Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)

  • Massachusetts General Hospital, Boston
Rekrutterer
Alder 18 til 85 · Alle køn · Opdateret 8. jan. 2026 · NCT05987852

Study of Novel Therapeutics for Acute Remedy of Colitis

  • Brigham and Women's Hospital, Chestnut Hill
  • Brigham and Women's Hospital, Chestnut Hill
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 20. okt. 2025 · NCT06420492

High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy

  • Boston Children's Hospital, Boston
RekruttererObservationsstudie
Alder 5 til 25 · Alle køn · Opdateret 3. mar. 2025 · NCT04331639

Family Members At INcreased-risk for Developing Inflammatory Bowel Disease

  • Massachusetts General Hospital, Boston
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 14 og opefter · Alle køn · Opdateret 20. dec. 2024 · NCT06655415

Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.